AbbVie Inc said on Tuesday it signed a U.S. licensing deal with Mylan NV for its proposed biosimilar to AbbVie’s blockbuster drug Humira, in a move that will give it more near-term control over the co…
leon-nanodrugs Supports Takeda in a Feasibility Assessment of leon’s Proprietary MicroJet Reactor (MJR®) Nano-Technology
Munich, Germany, July 17, 2018 / B3C newswire / — leon-nanodrugs GmbH (“leon”) is pleased to announce that its proprietary MicroJet Reactor (MJR®) nano-technology has been selected by…
Pfizer, Astellas’ Xtandi OK’d for second prostate cancer variant
The FDA approved Pfizer and Astellas Pharma’s Xtandi, or enzalutamide, as a treatment for men with non-metastatic castration- -More- …
Amgen seeks FDA nod for osteoporosis therapy
A biologics license application was resubmitted to the FDA by Amgen for Evenity, or romosozumab, being developed to treat pos -More- …